angelarleta
Contributor
I have a provider who performs peripheral nerve injections on a patient then the pt receives physical therapy by a PT on the same dos. Both services are documented separately and BCBS is denying the peripheral nerve injections as bundled to the physical therapy, stating the use of the modifier is not supported.
We bill as
97110-GP-59 DX M79.2, R20.9, R26.2, G89.29
64450-50-59 DX M79.671, M79.672
Peripheral Nerve Block Injection to B Sural / Peroneal / Saphenous Nerves.
The patient was placed in the semi-recumbent position. The skin over-lying the aforementioned nerves were prepped with hydrogen peroxide using aseptic technique. A 27g 1 1/2 in needle introduced through the skin to the proximity of the targeted nerves without complications. Following a negative aspiration, 1 ml of 0.25% Bupivicane was injected into each site without resistance. The needle was removed with the tip intact. Patient tolerated the procedure well with out complication or excessive bleeding. Patient was instructed to avoid strenuous activity involving the treated limb for the next 24hrs and to call immediately if localized redness, swelling, warmth, pain, or skin changes are noted.
NDC 0409-1160-18 Lot: GL1649 Exp: 08/01/2024.
What am I missing on these?
We bill as
97110-GP-59 DX M79.2, R20.9, R26.2, G89.29
64450-50-59 DX M79.671, M79.672
| Exercise | Sets & Repetitions | Time |
| strength training [97110] | hamstring glutes hips groin calf | 5 mins |
| PNF stretches[97110][97110] [97110] | hamstring glutes hips groin | 10 mins |
| Physio Max [97110] | hamstring glutes hips groin calf | 10 mins |
Peripheral Nerve Block Injection to B Sural / Peroneal / Saphenous Nerves.
The patient was placed in the semi-recumbent position. The skin over-lying the aforementioned nerves were prepped with hydrogen peroxide using aseptic technique. A 27g 1 1/2 in needle introduced through the skin to the proximity of the targeted nerves without complications. Following a negative aspiration, 1 ml of 0.25% Bupivicane was injected into each site without resistance. The needle was removed with the tip intact. Patient tolerated the procedure well with out complication or excessive bleeding. Patient was instructed to avoid strenuous activity involving the treated limb for the next 24hrs and to call immediately if localized redness, swelling, warmth, pain, or skin changes are noted.
NDC 0409-1160-18 Lot: GL1649 Exp: 08/01/2024.
What am I missing on these?